Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ARTH - ARCH THERAPEUTICS INC
Market Cap 1.99M P/E - EPS this Y - Ern Qtrly Grth -
Income -12.99M Forward P/E 0.11 EPS next Y - 50D Avg Chg -45.00%
Sales 148.16k PEG - EPS past 5Y - 200D Avg Chg -68.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -87.00%
Recommedations 3.00 Quick Ratio 0.00 Shares Outstanding 4.44M 52W Low Chg 28.00%
Insider Own 3.51% ROA -199.27% Shares Float 4.30M Beta 3.61
Inst Own 3.38% ROE - Shares Shorted/Prior -/- Price 1.55
Gross Margin 39.58% Profit Margin - Avg. Volume 667 Target Price -
Oper. Margin -3,304.36% Earnings Date Nov 7 Volume 2,920 Change 19.23%
Healthcare | Biotechnology | United States
About ARCH THERAPEUTICS INC

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

ARCH THERAPEUTICS INC News
10/01/24 Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
05/06/24 Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
ARTH Chatroom

User Image Jeko44 Posted - 5 months ago

$ARTH c’mon little Arch!

User Image JDT72 Posted - 6 months ago

$ARTH what's brought this back to life, the fact they will be presenting at another conference?

User Image DekmarTrades Posted - 6 months ago

HOTTEST STOCKS that have NEWS/ FILINGS Today! These are the stocks that you want to be watching this morning! $MGAM $ARTH $PSTV $CLOW $SGE

User Image SuzeyQ Posted - 7 months ago

$ARTH Any news on this one? Just heard it recommended. Is it halted? Or just no volume?

User Image HOLDTIGHT Posted - 8 months ago

User Image Lveiga77 Posted - 8 months ago

$ARTH what happened? Anyone know why the drop?

User Image HOLDTIGHT Posted - 9 months ago

$ARTH come on! Such a great product

User Image cctranscripts Posted - 01/22/24

Michael Parker just provided an update on share ownership of Arch Therapeutics, Inc. https://www.conferencecalltranscripts.org/summary/?id=12883305 $ARTH

User Image Last10K Posted - 10 months ago

$ARTH just filed with the SEC a Accountant Change and a Financial Exhibit https://last10k.com/sec-filings/ARTH/0001437749-24-001286.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ARTH

User Image cctranscripts Posted - 10 months ago

Changes in https://www.conferencecalltranscripts.org/summary/?id=12864109 $ARTH

User Image risenhoover Posted - 10 months ago

$ARTH / Arch Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 ARCH THERAPEUTICS https://fintel.io/doc/sec-arch-therapeutics-inc-1537561-8k-2024-january-12-19734-399?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Jeko44 Posted - 10 months ago

$ARTH extended, again, completion of an uplist to Nasdaq market or nyse until March 15. Let’s hope it happens this year

User Image cctranscripts Posted - 10 months ago

Entry into a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12861055 $ARTH

User Image Last10K Posted - 10 months ago

$ARTH just filed with the SEC a New Agreement and a Financial Exhibit https://last10k.com/sec-filings/ARTH/0001437749-24-001204.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ARTH

User Image risenhoover Posted - 10 months ago

$ARTH / Arch Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2024 ARCH THERAPEUTICS https://fintel.io/doc/sec-arch-therapeutics-inc-1537561-8k-2024-january-11-19733-111?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Manipulation13F Posted - 10 months ago

$ARTH 👀

User Image cctranscripts Posted - 12/29/23

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10- https://www.conferencecalltranscripts.org/summary/?id=12831152 $ARTH

User Image risenhoover Posted - 12/29/23

$ARTH / Arch Therapeutics files form NT 10-K https://fintel.io/doc/sec-arch-therapeutics-inc-1537561-nt-10k-2023-december-29-19720-6317?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image JDT72 Posted - 11 months ago

$ARTH I am utterly confused here, they had to take out another $500K loan on top of the $250K from a few weeks back and the price goes up? I want to like this stock but can anyone explain how that is good news?

User Image Last10K Posted - 11 months ago

$ARTH just filed with the SEC a New Financial Obligation https://last10k.com/sec-filings/ARTH/0001437749-23-034574.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ARTH

User Image risenhoover Posted - 11 months ago

$ARTH / Arch Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2023 ARCH THERAPEUTI https://fintel.io/doc/sec-arch-therapeutics-inc-1537561-8k-2023-december-15-19706-9950?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Logic102 Posted - 11 months ago

$ARTH every time this company appears to be beginning to get its act together there's another major Manure Show in action. Sad

User Image Jeko44 Posted - 11 months ago

$ARTH VP of sales just resigned. The intrigue deepens… PS - 44 watchers now!

User Image cctranscripts Posted - 11 months ago

Departure of Directors or Certain https://www.conferencecalltranscripts.org/summary/?id=12777762 $ARTH

User Image Last10K Posted - 11 months ago

$ARTH just filed with the SEC a Event for Officers https://last10k.com/sec-filings/ARTH/0001437749-23-034016.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ARTH

User Image timfris Posted - 11 months ago

$ARTH they will need to raise soon. Look out for offering Friday at 4. Just my opinion.

User Image HOLDTIGHT Posted - 11 months ago

$ARTH Up Up Up Up Up Up Up Up Up Up Up Up

User Image Jeko44 Posted - 11 months ago

$ARTH so someone advanced them $250k to keep the lights on? My take on the 8-k

User Image cctranscripts Posted - 11 months ago

Creation of a Direct Financial Obligation or an Obligation under an https://www.conferencecalltranscripts.org/summary/?id=12766568 $ARTH

User Image Last10K Posted - 11 months ago

$ARTH just filed with the SEC a New Financial Obligation https://last10k.com/sec-filings/ARTH/0001437749-23-033655.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ARTH

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ABRAMS MICHAEL S CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Aug 31 Buy 0.275 10,292 2,830 10,292 09/08/23
Norchi Terrence W PRESIDENT AND CHIEF.. PRESIDENT AND CHIEF EXECUTIVE Aug 31 Buy 0.275 6,862 1,887 6,862 09/08/23
Hicks Laurence Director Director Aug 31 Buy 0.275 10,292 2,830 10,292 09/08/23